Taizong Biotech Co., Ltd. 2026 Q1 EPS -0.45 TWD
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Taizong Biotech Co., Ltd. announced its Q1 2026 financial results, reporting a net loss with an EPS of -0.45 TWD. The company generated 173 million TWD in revenue and a net profit of -26 million TWD, indicating a challenging quarter for the biotechnology and medical company.